Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers

7 May 2023

Abstract excerpt

Aging | doi:10.18632/aging.204701. Parinya Samakkarnthai, Dominik Saul, Lei Zhang, Zaira Aversa, Madison L. Doolittle, Jad G. Sfeir, Japneet Kaur, Elizabeth J. Atkinson, James R. Edwards, Graham G. Russell, Robert J. Pignolo, James L. Kirkland, Tamar Tchkonia, Laura J. Niedernhofer, David G. Monroe, Nathan K. Lebrasseur, Joshua N. Farr, Paul D. Robbins, Sundeep Khosla

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37154858
DOI: 10.18632/aging.204701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markersPMID 37154858Read ↗

Recent advances in senescence-associated secretory phenotype and osteoporosisSemantic proximity Read ↗

<i>In vitro</i> and <i>in vivo</i> effects of zoledronate on senescence and senescence-associated secretory phenotype markersSemantic proximity Read ↗

Senescent cells: A therapeutic target for osteoporosisSemantic proximity Read ↗

Cellular senescence and other age-related mechanisms in skeletal diseasesSemantic proximity Read ↗

Skeletal Aging and Osteoporosis: Mechanisms and TherapeuticsSemantic proximity Read ↗

Senescence-associated secretory phenotype and its impact on oral immune homeostasisSemantic proximity Read ↗

"Bone-SASP" in Skeletal Aging.Semantic proximity Read ↗

Cellular senescence in skeletal diseases: A bibliometric analysis from 2007 to 2024Semantic proximity Read ↗

The Role of Senescence-Associated Secretory Phenotype in Bone LossSemantic proximity Read ↗

Targeting senescent cells by dasatinib and quercetin ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration.Semantic proximity Read ↗

Achilles' spear: A new therapeutic target for age‐related diseasesSemantic proximity Read ↗

Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatmentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.